Peterborough City Hospital’s Oncology Clinical Research Team has recruited the first UK patient to an international trial that explores less invasive treatments for patients with breast cancer.
The hospital, run by North West Anglia NHS Foundation Trust, is one of 122 sites across the globe taking part in the FeDeriCa trial, a study that looks at a new method of delivering two cancer drugs.
Dr Karen McAdam, Consultant Oncologist and Principal Investigator for the trial, said: “The drugs are currently administered separately via a drip over and may be given for up to 12 months; however, the trial investigates the effectiveness of combining the drugs and administering them together as an injection. The new combination drug is delivered over a shorter period of time, which could potentially reduce the length of time a patient is in hospital for while having their treatment.
“We are very excited to have recruited the first UK patient to the trial. We want to ensure that our patients have access to the most up-to-date and effective treatments and this is achieved by research.”
If you would like more information about Clinical Research at North West Anglia NHS Foundation Trust, please contact email@example.com.
Back to trust news